[EN] AMINOPYRIDINE-BASED MTA-COOPERATIVE PRMT5 INHIBITORS<br/>[FR] INHIBITEURS DE PRMT5 À COOPÉRATION AVEC LA MTA À BASE D'AMINOPYRIDINE
申请人:[en]MIRATI THERAPEUTICS, INC.
公开号:WO2023278564A1
公开(公告)日:2023-01-05
The present invention relates to compounds that inhibit Protein Arginine N- Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.